May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
The Effect of Lisinopril Treatment in ERG Oscillatory Potentials Amplitude in Normotensive Diabetic Type 2 Patients
Author Affiliations & Notes
  • M. Parrochia
    Retina, APEC, Mexico DF, Mexico
  • P. Covarrubias
    Retina, APEC, Mexico DF, Mexico
  • H. Quiroz–Mercado
    Retina, APEC, Mexico DF, Mexico
  • J. Jimenez
    Retina, APEC, Mexico DF, Mexico
  • Footnotes
    Commercial Relationships  M. Parrochia, None; P. Covarrubias, None; H. Quiroz–Mercado, None; J. Jimenez, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 349. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Parrochia, P. Covarrubias, H. Quiroz–Mercado, J. Jimenez; The Effect of Lisinopril Treatment in ERG Oscillatory Potentials Amplitude in Normotensive Diabetic Type 2 Patients . Invest. Ophthalmol. Vis. Sci. 2005;46(13):349.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate the effect of Lisinopril therapy on ERG oscillatory potential in normotensive diabetics patients without retinopathy. Methods: We recruited normotensive diabetic patients without retinopathy with less than 5 years of disease. Adults with an average of 45 years old. All patients underwent full physical examination including BP, 24 hours urine analysis, glycosilate hemoglobine, HB, and fundus photographs. ERG oscillatory potentials were done before and after3 months of the beginning of treatment with oral Lisinopril 10 mg. Results: We have seen an oscillatory potentials amplitude normalization tendency in each 4 waves of each oscillatory potential between pre–treatment and 3 month post–treatment exams. Average values for OD and OS for each wave at 3 month control was: In OD wave nº1 improved 0.62 uv, wave nº2 improved 0.03 uv, wave nº3 improved 2.6 uv, and wave nº4 decreased 1.69 uv . In OS wave nº1 improved 1.14, wave nº2 improved 4.34 uv, wave nº3 improved 2.64 uv, and wave nº4 decreased 0.64 uv. Conclusions: The study showed that Lisinopril therapy produced improvement in oscillatory potentials amplitude in normotensive tipe II diabetics.

Keywords: diabetes • diabetic retinopathy • electrophysiology: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×